Innate immunity defines the capacity of antiviral T cells to limit persistent infection
about
Recognition and Regulation of T Cells by NK Cells"Natural Regulators": NK Cells as Modulators of T Cell ImmunityNK Cells in HIV DiseaseNK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell EngraftmentEvasion from NK cell-mediated immune responses by HIV-1Genomic Modifiers of Natural Killer Cells, Immune Responsiveness and Lymphoid Tissue Remodeling Together Increase Host Resistance to Viral InfectionNatural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse CytomegalovirusTargeting of a natural killer cell receptor family by a viral immunoevasinBoosting vaccine efficacy the natural (killer) wayInnate or adaptive immunity? The example of natural killer cellsAcute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity.Licensing delineates helper and effector NK cell subsets during viral infection.Effective control of viral infections by the adaptive immune system requires assistance from innate immunity.Expression pattern of CD11c on lung immune cells after disseminated murine cytomegalovirus infection.Deciphering the role of DC subsets in MCMV infection to better understand immune protection against viral infectionsAbsence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells.Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses.Murine CD4+ T cell responses are inhibited by cytotoxic T cell-mediated killing of dendritic cells and are restored by antigen transfer.UNC93B1 mediates innate inflammation and antiviral defense in the liver during acute murine cytomegalovirus infection.Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune responseNK cells and virus-related cancers.Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.Rapid and sequential quantitation of salivary gland-associated mouse cytomegalovirus in oral lavageIL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence.Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution.NK cells and their ability to modulate T cells during virus infectionsInteractions of human myeloid cells with natural killer cell subsets in vitro and in vivoMutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection.Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains.A Functional Type I Interferon Pathway Drives Resistance to Cornea Herpes Simplex Virus Type 1 Infection by Recruitment of LeukocytesCytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.Constitutive but not inducible attenuation of transforming growth factor β signaling increases natural killer cell responses without directly affecting dendritic cells early after persistent viral infection.Perforin is a critical physiologic regulator of T-cell activation.Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C.NK cells: immune cross-talk and therapeutic implications.Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell functionYet another role for natural killer cells: cytotoxicity in immune regulation and viral persistence.High IFN-gamma and TNF production by peripheral NK cells of Colombian patients with different clinical presentation of Plasmodium falciparum.The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response.
P2860
Q26742166-8B2664C5-EC69-4B43-A4DA-4E2BE6AEE6BBQ26744551-F5EBB078-FD09-4250-BF1F-0F8F2FAFA7D0Q26752833-F9AD85DD-5C48-47E8-8E08-4B67E89C4AD7Q26765845-FE8F8D33-DD5B-4096-A044-F52D4DCDDAA9Q26864489-0AA18B3C-07AA-4A39-8BC2-6FE15BB116CEQ27316041-FA089FCD-5C76-4257-969F-EC57E277EB9DQ27319958-547FBD52-BFCA-4818-8950-222D75641087Q27684601-617600BC-175B-4044-91B7-4CC8AF1E8C23Q28084474-4C3C1888-116D-4AEB-B4C5-99A234DAFA73Q29615106-D676C778-E85A-445D-BB55-FCABDCB24237Q30275560-D75E3D62-E33C-4CC9-9212-92000F00845DQ30426938-766EECEE-1C87-4CFC-8E18-83503398C54EQ33703214-9F5F33EB-12C1-4115-93CD-375CB0AB6FE6Q33710906-65864FD3-41EF-4246-8ADF-BA956A9CC5E7Q33916666-ACABB4ED-8A0C-4F6A-8D87-7A09A67F9EF3Q33965560-5F8B8483-383D-4CA6-8495-F130A020766DQ34013634-C269C8EE-C043-44ED-88A9-F28EEE8DF8B2Q34030338-ED0B0242-2D11-4FFD-A319-2C964C05F41CQ34287488-FE22D614-9E77-496B-841A-A3BA010311A6Q34314248-CDE920B7-8CE5-43DE-A357-A0899E661890Q34314259-74784B93-6BAB-4C9A-8205-A278DE5AADB3Q34337237-0E3273DC-7DD9-4ADE-852A-13AE9E3B9407Q34360228-7498D0AF-A18C-480C-B690-C6B1A4B9D10AQ34364358-128C4EFA-1260-4EDF-A8C7-428EFFB24F16Q34372333-CE3CDD31-B09C-4FF8-A0AA-B9ED5E880895Q34539825-B1F3CE16-F236-40DD-B7CB-BF367E701513Q34700499-2F0CE0C4-853C-4FD6-9D6E-F8029457779CQ34895966-E2DC41AF-B110-4BCE-BEE8-2704BEA7C659Q34959053-CA371FDD-4FC1-4432-9996-E697BACA27DBQ34973765-EC5D90F9-1F07-4B86-9212-D4E3A5441A84Q35058178-9A8A7AE0-5F11-4994-876B-8D173D3C6E02Q35086196-67E28C08-B8A1-44F6-AF25-F4F80868EBFFQ35111019-276FC330-C1E9-4D42-A028-57B981033CE6Q35125914-160BC84A-3FB4-4EDF-9CB1-F6F49B6C7C95Q35155996-5A809174-9FDB-4045-BFFF-B478B9A8271BQ35591444-9F1025DE-F2A2-4F81-B713-322875BC1B04Q35678598-F4F1B175-A91A-4F79-9933-C42F20644313Q35751059-F8FA51CB-2439-43EB-A466-11D71398C1B1Q35800108-D77FE244-B5D3-4880-9C21-13E994A271FCQ35826529-969CD1D5-96EF-4FF4-A611-349D18F47E14
P2860
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
@ast
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
@en
type
label
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
@ast
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
@en
prefLabel
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
@ast
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
@en
P2093
P2860
P50
P356
P1476
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
@en
P2093
Andrea Khong
Anthony A Scalzo
Hyacinth Tabarias
Mariapia A Degli-Esposti
Matthew E Wikstrom
Peter Fleming
Robbert G van der Most
Valentina Voigt
P2860
P304
P356
10.1084/JEM.20091193
P407
P577
2010-05-31T00:00:00Z